Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04089904
Brief Title: Phase II Trial of Neoadjuvant Pembrolizumab for Patients With Early Stage Gastroesophageal Adenocarcinoma

First Submitted : August 20, 2019
First Submitted that Met QC Criteria : September 12, 2019
First Posted : September 13, 2019

Last Update Submitted that Met QC Criteria : June 7, 2021
Last Update Posted : June 8, 2021